Medical Education Library

Optimal Duration of Antiplatelet Therapy Following Acute Coronary Syndrome

Funding for this newsletter series was provided by AstraZeneca.

 

The Cardiovascular Insights for Primary Care Physicians eNewsletter Series summarizes key information and data on common cardiovascular issues facing primary care physicians today.

Optimal Duration of Antiplatelet Therapy Following Acute Coronary Syndrome is the fourth eNewsletter in this series.

Click here to read the supplement.

Recommended Reading

MACRA Monday: Depression screening
MDedge Family Medicine
Medicaid’s share of state budgets continues to grow
MDedge Family Medicine
Acne severity shows negative impact on women’s self esteem
MDedge Family Medicine
Adolescents’ use of opioids, cigarettes is down; pot use is up
MDedge Family Medicine
Counseling parents may curb nonmedical vaccine exemptions
MDedge Family Medicine
FDA approves tofacitinib for psoriatic arthritis
MDedge Family Medicine
FDA approves Eskata for treatment of raised SKs
MDedge Family Medicine
MMRV vaccine cut chickenpox hospitalizations in young Brazilian children
MDedge Family Medicine
Maternal mortality is set to be a top issue for 2018
MDedge Family Medicine
ADA guidelines embrace heart health
MDedge Family Medicine